跳至主要内容

Cronkhite-Canada Syndrome: A Case Report and Literature Review of Gastrointestinal Polyposis Syndrome

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52581#.VJuJocCAM4

Cronkhite-Canada syndrome (CCS) is a rare, non-inherited polyposis syndrome, characterized by diffuse gastrointestinal (GI) hamartomatous polyposis with unique dermatologic changes including alopecia, skin hyperpigmentation, and nail dystrophy. Patients can typically present with diarrhea, weight loss, protein-losing enteropathy, and nutritional deficiency. However, it can demonstrate diverse other clinical features, usually with poor prognosis. Currently, there are no specific diagnostic criteria established yet. The etiology of CCS is still obscure, but an autoimmune process has been suggested. Here we present an 81-year-old Caucasian female who had clinical presentations, physical exam, imaging, endoscopy and pathology findings that were all consistent with the diagnosis of CCS. We also include a detailed literature review of the other gastrointestinal polyposis syndromes (hamartomatous, adenomatous, hyperplastic and inflammatory polyposis). A high index of suspicion and recognition of the characteristic clinical, endoscopic as well as histopathological findings of CCS, as well as different gastrointestinal polyposis conditions, can help clinicians with more timely and correct diagnosis.
Cite this paper
Shen, X. , Husson, M. and Lipshutz, W. (2014) Cronkhite-Canada Syndrome: A Case Report and Literature Review of Gastrointestinal Polyposis Syndrome. Case Reports in Clinical Medicine, 3, 650-659. doi: 10.4236/crcm.2014.312138. 
 

[1] Cronkhite, L.W. and Canada, W.J. (1955) Generalized Gastrointestinal Polyposis; an Unusual Syndrome of Polyposis, Pigmentation, Alopecia and Onychotropia. The New England Journal of Medicine, 252, 1011-1015.
http://dx.doi.org/10.1056/NEJM195506162522401
[2] Ward, E.M. and Wolfsen, H.C. (2002) Review Article: The Non-Inherited Gastrointestinal Polyposis Syndromes. Alimentary Pharmacology Therapeutics, 16, 333-342. http://dx.doi.org/10.1046/j.1365-2036.2002.01172.x
[3] Daniel, E.S., Ludwig, S.L., Lewin, K.J., Ruprecht, R.M., Rajacich, G.M. and Schwabe, A.D. (1982) The Cronkhite-Canada Syndrome: An Analysis of Clinical and Pathologic Features and Therapy in 55 Patients. Medicine, 61, 293-309.
[4] Goto, A. (1995) Cronkhite-Canada Syndrome: Epidemiological Study of 110 Cases Reported in Japan. GekaHokan, 64, 3-14.
[5] Sweetser, S., Ahlquist, D.A., Osborn, N.K., Sanderson, S.O., Smyrk, T.C., Chari, S.T. and Boardman, L.A. (2012) Clinicopathologic Features and Treatment Outcomes in Cronkhite-Canada Syndrome: Support for Autoimmunity. Digestive Diseases and Sciences, 57, 496-502. http://dx.doi.org/10.1007/s10620-011-1874-9
[6] Riegert-Johnson, D.L., Osborn, N., Smyrk, T. and Boardman, L.A. (2007) Cronkhite-Canada Syndrome Hamartomatous Polyps Are Infiltrated with IgG4 Plasma Cells. Digestion, 75, 96-97. http://dx.doi.org/10.1159/000102963
[7] Takeuchi, Y., Yoshikawa, M., Tsukamoto, N., Shiroi, A., Hoshida, Y., Enomoto, Y., Kimura, T. and Fukui, H. (2003) Cronkhite-Canada Syndrome with Colon Cancer, Portal Thrombosis, High Titer of Anti-Nuclearantibodies, and Membranous Glomerulonephritis. Journal of Gastroenterology, 38, 791-795. http://dx.doi.org/10.1007/s00535-002-1148-6
[8] Patil, V., Patil, L.S., Jakareddy, R., Verma, A. and Gupta, A.B. (2013) Cronkhite-Canada Syndrome: A Report of Two Familial Cases. Indian Journal of Gastroenterology, 32, 119-122. http://dx.doi.org/10.1007/s12664-012-0296-8
[9] Kato, K., Ishii, Y., Mazaki, T., Uehara, T., Nakamura, H. and Tanaka, M. (2013) Spontaneous Regression of Polyposis Following Abdominal Colectomy and Helicobacter pylori Eradication for Cronkhite-Canada Sydrome. Case Reports in Gastroenterology, 7, 140-146. http://dx.doi.org/10.1159/000350321
[10] Okamoto, K., Isomoto, H., Shikuwa, S., Nishiyama, H., Ito, M. and Kohno, S. (2008) A Case of Cronkhite-Canada Syndrome: Remission after Treatment with Anti-Helicobacter pylori Regimen. Digestion, 78, 82-87.
http://dx.doi.org/10.1159/000165354
[11] Isobe, T., Kobayashi, T., Hashimoto, K., Kizaki, J., Miyagi, M., Aoyagi, K., Koufuji, K. and Shirouzu, K. (2013) Cronkhite-Canada Syndrome Complicated with Multiple Gastric Cancers and Multiple Colon Adenomas. American Journal of Case Reports, 14, 120-128. http://dx.doi.org/10.12659/AJCR.889083
[12] Jain, A., Nanda, S., Chakraborty, P., Kundra, A., Anuradha, S., Reddy, B.S. and Kar, P. (2003) Cronkhite-Canada Syndrome with Adenomatous and Carcinomatous Transformation of Colonic Polyp. Indian Journal of Gastroenterology, 22, 189-190.
[13] Malhotra, R. and Sheffield, A. (1988) Cronkhite-Canada Syndrome Associated with Colon Carcinoma and Adenomatous Changes in C-C Polyps. The American Journal of Gastroenterology, 83, 772-776.
[14] Nagata, J., Kijima, H., Hasumi, K., Suzuki, T., Shirai, T. and Mine, T. (2003) Adenocarcinoma and Multiple Adenomas of the Large Intestine, Associated with Cronkhite-Canada Syndrome. Digestive and Liver Disease, 35, 434-438.
http://dx.doi.org/10.1016/S1590-8658(03)00160-9
[15] Ward, E.M. and Wolfsen, H.C. (2003) Pharmacological Management of Cronkhite-Canada Syndrome. Expert Opinion on Pharmacotherapy, 4, 385-389. http://dx.doi.org/10.1517/14656566.4.3.385
[16] Aretz, S. (2010) The Differential Diagnosis and Surveillance of Hereditary Gastrointestinal Polyposis Syndromes. Deutsches Arzteblatt International, 107, 163-173.
[17] Seshadri, D., Karagiorgos, N. and Hyser, M.J. (2012) A Case of Cronkhite-Canada Syndrome and a Review of Gastrointestinal Polyposis Syndromes. Gastroenterology & Hepatology, 8, 197-201.
[18] Shah, N.B. and Lindor, N.M. (2010) Lower Gastrointestinal Tract Cancer Predisposition Syndromes. Hematology/ Oncology Clinics of North America, 24, 1229-1252. http://dx.doi.org/10.1016/j.hoc.2010.08.012
[19] Kastrinos, F. and Syngal, S. (2011) Inherited Colorectal Cancer Syndrome. Cancer Journal, 17, 405-415.
http://dx.doi.org/10.1097/PPO.0b013e318237e408
[20] Brosens, L.A., Langeveld, D., van Hattem, W.A., Giardiello, F.M. and Offerhaus, G.J. (2011) Juvenile Polyposis Syndrome. World Journal of Gastroenterology, 17, 4839-4844. http://dx.doi.org/10.3748/wjg.v17.i44.4839
[21] Zbuk, K.M. and Eng, C. (2007) Hamartomatous Polyposis Syndrome. Nature Clinical Practice. Gastroenterology & Hepatology, 4, 492-502.
[22] Howe, J.R., Mitros, F.A. and Summers, R.W. (1998) The Risk of Gastrointestinal Carcinoma in Familial Juvenile Polyposis. Annals of Surgical Oncology, 5, 751-756. http://dx.doi.org/10.1007/BF02303487
[23] Calva, D. and Howe, J.R. (2008) Hamartomatous Polyposis Syndrome. Surgical Clinics of North America, 88, 779-817.
http://dx.doi.org/10.1016/j.suc.2008.05.002
[24] Brosens, L.A., van Hattem, A., Hylind, L.M., Iacobuzio-Donahue, C., Romans, K.E., Axilbund, J., Giardiello, F.M., et al. (2007) Risk of Colorectal Cancer in Juvenile Polyposis. Gut, 56, 965-967.
http://dx.doi.org/10.1136/gut.2006.116913
[25] Gammon, A., Jasperson, K., Kohlmann, W. and Burt, R.W. (2009) Hamartomatous Polyposis Syndromes. Best Practice & Research Clinical Gastroenterology, 23, 219-231. http://dx.doi.org/10.1016/j.bpg.2009.02.007
[26] Jass, J.R. (2008) Colorectal Polyposes: From Phenotype to Diagnosis. Pathology-Research and Practice, 204, 431-447.
http://dx.doi.org/10.1016/j.prp.2008.03.008
[27] Schreibman, I.R., Baker, M., Amos, C. and McGarrity, T.J. (2005) The Hamartomatous Polyposis Syndromes: A Clinical and Molecular Review. The American Journal of Gastroenterology, 100, 476-490.
http://dx.doi.org/10.1111/j.1572-0241.2005.40237.x
[28] Bülow, S., Björk, J., Christensen, I.J., Fausa, O., Järvinen, H., Moesgaard, F. and Vasen, H.F.A., DAF Study Group (2004) Duodenal Adenomatosis in Familial Adenomatous Polyposis. Gut, 53, 381-386.
http://dx.doi.org/10.1136/gut.2003.027771
[29] Omundsen, M. and Lam, F.F. (2012) The Other Colonic Polyposis Syndromes. ANZ Journal of Surgery, 82, 675-681.
http://dx.doi.org/10.1111/j.1445-2197.2012.06140.x
[30] Wynter, C.V., Walsh, M.D., Higuchi, T., Leggett, B.A., Young, J. and Jass, J.R. (2004) Methylation Patterns Define Two Types of Hyperplastic Polyp Associated with Colorectal Cancer. Gut, 53, 573-580.
http://dx.doi.org/10.1136/gut.2003.030841
[31] Jass, J.R. (2004) Hyperplastic Polyps and Colorectal Cancer: Is There a Link? Clinical Gastroenterology and Hepatology, 2, 1-8. http://dx.doi.org/10.1016/S1542-3565(03)00284-2
[32] Ng, K.H., Mathur, P., Kumarasinghe, M.P., Eu, K.W. and Seow-Choen, F. (2004) Cap Polyposis: Further Experience and Review. Diseases of the Colon & Rectum, 47, 1208-1215. http://dx.doi.org/10.1007/s10350-004-0561-8
[33] Petris, G.D., Dhungel, B.M., Chen, L. and Pasha, S.F. (2013) Inflammatory “Cap” Polyposis: A Case Report of a Rare Nonneoplastic Colonic Polyposis. International Journal of Surgical Pathology, 22, 378-382.
http://dx.doi.org/10.1177/1066896913501383                  eww141225lx
标签：

评论

发表评论

此博客中的热门博文

Electron Spin and Proton Spin in the Hydrogen and Hydrogen-Like Atomic Systems

Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52202#.VIj7tMnQrzE Author(s) Stanisław Olszewski * Affiliation(s) Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland . ABSTRACT The mechanical angular momentum and magnetic moment of the electron and proton spin have been calculated semiclassically with the aid of the uncertainty principle for energy and time. The spin effects of both kinds of the elementary particles can be expressed in terms of similar formulae. The quantization of the spin motion has been done on the basis of the old quantum theory. It gives a quantum number n = 1/2 as the index of the spin state acceptable for both the electron and proton ...
发表评论
阅读全文

Incorporation of High-Altitude Balloon Experiment in High School Science Classrooms

High-altitude balloon is a balloon, filled usually with helium or hydrogen that ascends into an area called “near space” or stratosphere. The most common type of high-altitude balloons are weather balloons. Other purposes include use as a platform for experiments in the upper atmosphere. Modern balloons generally contain electronic equipment such as radio transmitters, cameras, or satellite navigation systems, such as GPS receivers. The mission of the High-Altitude Balloon Experiment (HABE) is to acquire supporting data, validate enabling technologies, and resolve critical acquisition, tracking, and pointing (ATP) and fire control issues in support of future space-based precision pointing experiments. The use of high-altitude balloons offers a relatively low-cost, low-vibration test platform, a recoverable and reusable payload, worldwide launch capability, and a 'near- space' emulation of the future space systems operational scenarios. More recently, several university...
1 条评论
阅读全文

Fermented Brown Sugar Residue Prolongs the Caenorhabditis elegans Lifespan via DAF-16

Fermented brown sugar residue (FBSR) is generated in the course of purifying biomass ethanol from the yeast fermentation products of brown sugar. It contains abundant nutrition and is used in various industrial applications including as fertilizer and feed. Meanwhile, brown sugar has attracted attention as a health food and is thought to prevent cardiovascular diseases, hypertension, and brain stem diseases. Furthermore, polyphenol, contained in brown sugar, reduces oxidative stress and inhibits glucose absorption. DAF-16 is a transcription factor regulated downstream of the insulin signaling pathway and is one of the main factors contributing to aging and lifespan in C. elegans . Therefore, to determine the precise roles of the DAF-16 transcription factor in stress tolerance and life span, it is necessary to elucidate the signaling pathways involved in DAF-16 activation. This study was designed to elucidate the molecular mechanisms controlling the physiological stress toleran...
发表评论
阅读全文